Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic CancerMonday, 14 October 2019 at 14:30 Add to Calendar ▼2019-10-14 14:30:002019-10-14 15:30:00Europe/LondonOrganoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer3D-Culture and Organoids 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com New approaches to prioritize treatment strategies are urgently needed to improve survival and quality of life for pancreatic cancer patients. Combined genomic, transcriptomic, and therapeutic profiling of patient-derived organoids can identify molecular and functional subtypes of pancreatic cancer, predict therapeutic responses and facilitate precision medicine for pancreatic cancer patients. |